Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIO2 Polymorphism and T4+T3 Treatment in Thyroid Cancer
NCT05247476Phase 4Unknown
- Sponsor
- Xiamen University Zhongshan Hospital
- Start
- Oct 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liothyronine in hypothyroidism, sponsored by Xiamen University Zhongshan Hospital. Status: unknown.
02
Drugs
liothyronine
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on NCT05247476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05247476.